Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Journal of Medicinal Chemistry
|
January 15, 2009
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors
Cecilia Martelli, Daniela Alderighi, Marcella Coronnello, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer
Tiziano Marzo, Lara Massai, Alessandro Pratesi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer
Giuseppe Toffoli, Erika Cecchin, Giampiero Gasparini, et al.
Annals of Nuclear Medicine
|
October 30, 2022
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study
Flavia Linguanti, Elisabetta M Abenavoli, Vittorio Briganti, et al.
Oncology Research
|
August 24, 2006
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules
Alessio Tempestini, Barbara Caciagli, Maria Morganti, et al.
Medycyna Pracy
|
November 14, 2022
Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs)
Stefano Dugheri, Nicola Mucci, Elisabetta Bucaletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2005
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers
Maria Morganti, Monica Ciantelli, Beatrice Giglioni, et al.
JAMA Oncology
|
January 16, 2016
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial
Julien Taieb, Aziz Zaanan, Karine Le Malicot, et al.
International Journal of Cancer
|
April 12, 2019
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
Enrico Mini, Andrea Lapucci, Gabriele Perrone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 19, 2008
Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)
Ivan Popov, Alfredo Carrato, Alberto Sobrero, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Journal of Medicinal Chemistry
|
January 15, 2009
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors
Cecilia Martelli, Daniela Alderighi, Marcella Coronnello, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer
Tiziano Marzo, Lara Massai, Alessandro Pratesi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2009
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer
Giuseppe Toffoli, Erika Cecchin, Giampiero Gasparini, et al.
Annals of Nuclear Medicine
|
October 30, 2022
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study
Flavia Linguanti, Elisabetta M Abenavoli, Vittorio Briganti, et al.
Oncology Research
|
August 24, 2006
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules
Alessio Tempestini, Barbara Caciagli, Maria Morganti, et al.
Medycyna Pracy
|
November 14, 2022
Monitoring surface contamination for thirty antineoplastic drugs: a new proposal for surface exposure levels (SELs)
Stefano Dugheri, Nicola Mucci, Elisabetta Bucaletti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2005
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers
Maria Morganti, Monica Ciantelli, Beatrice Giglioni, et al.
JAMA Oncology
|
January 16, 2016
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial
Julien Taieb, Aziz Zaanan, Karine Le Malicot, et al.
International Journal of Cancer
|
April 12, 2019
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
Enrico Mini, Andrea Lapucci, Gabriele Perrone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 19, 2008
Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)
Ivan Popov, Alfredo Carrato, Alberto Sobrero, et al.
Page
of 14